.jpg)
Opinion: Biosimilars competition helps patients more than generic competition
Much of the current drug-pricing agenda proposed by President Biden and by Congress is based…
Author: STAT
‘Naively ambitious’: How COVAX failed on its promise to vaccinate the world
Around the world this spring, country after country awaited their first Covid-19 vaccine shipments. They’d…
CDC director defends decision to overrule expert panel on Covid booster shots for health and other front-line workers
Rochelle Walensky, director of the Centers for Disease Control and Prevention, on Thursday defended herself…
STAT+: FDA halts Allogene blood cancer trials after patient found to have ‘chromosomal abnormality’
Allogene Therapeutics said Thursday that the Food and Drug Administration had placed a hold on…
STAT+: AbbVie loses a lawsuit over Humira trade secrets it claimed were stolen
In a setback to AbbVie (ABBV), a U.S. federal court judge dismissed a lawsuit in…
Listen: Shkreli on film, the next NIH director, and a looming FDA deadline
Did we learn anything from the Martin Shkreli saga? Who will run the NIH? And…
STAT+: Europe’s largest clinical trial sponsors are getting better at reporting results
More than two dozen of the largest universities and hospitals in Europe have shown a…
STAT+: Moderna plans a vaccine plant in Africa, but critics say the move isn’t enough to ensure access
Amid intense concern that low-income countries lack access to Covid-19 vaccines, Moderna (MRNA) announced plans…
In digital health, Series A has become the new Series B
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Pharmalittle: White House and Moderna battle over global vaccine donations; Pfizer seeks FDA OK for kids to get its Covid shot
Rise and shine, everyone, another busy day is on the way. This morning is getting…
STAT+: Disappointing tumor responses, more side effects, seen with latest Amgen KRAS combination studies
Combining Amgen’s KRAS-blocking cancer drug Lumakras with other targeted medicines led to higher rates of…
STAT+: Backed with $500 million, a startup aims to rethink psychiatric drug development
For more than a decade, psychiatry has been a graveyard for new medicines. While in…
Opinion: A federal drug purchasing program could save billions
When Amazon, Berkshire Hathaway, and JPMorgan announced they were creating a new health care company…
Opinion: Covid-19 keeps delivering lessons about health care worker burnout. Will we learn them?
With the authorizations for several effective vaccines against Covid-19 and a strong vaccination program in…
In ‘Unequal Cities,’ authors aim to debunk the idea that genetics, rather than racism, causes health disparities
As Chicago-based health equity researchers, Maureen Benjamins and Fernando De Maio have long been interested…
STAT+: Here’s who might replace Francis Collins as NIH director
WASHINGTON — Almost as soon as Francis Collins announced that he’ll soon step down as…
STAT+: Older Americans bore the brunt of antibiotic-resistant infections, study finds
Older Americans were disproportionately affected by several different types of infection for which antibiotics were…
‘Reaching a detente’ with SARS-CoV-2: Helen Branswell on covering Covid-19, misinformation and more
On Wednesday, STAT senior writer Helen Branswell spoke with Seth Mnookin, director of the MIT…
Biden moves to ramp up at-home Covid-19 testing
The White House announced on Wednesday a $1 billion purchase of at-home rapid tests for…
In major decision, WHO recommends broad rollout of world’s first malaria vaccine
The World Health Organization, acting on a recommendation from its scientific advisers, announced Wednesday that…
STAT+: Northwest Bio marks ignominious anniversary of brain tumor study delay with silence
Northwest Biotherapeutics has buried data from its completed brain cancer clinical trial for so long…
STAT+: Pharmalittle: Henrietta Lacks estate plans to sue more companies; Sweden halts Moderna Covid shot for people 30 and younger
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
Two scientists win chemistry Nobel for discovering a new way to construct molecules, speeding up drug development
Scientists Benjamin List and David MacMillan won the Nobel Prize in chemistry Wednesday for discovering…
Lawyers for Henrietta Lacks estate say more companies to be sued over use of her cells
Trillions of her cells have played a pivotal role in medical research for the past…
Listen: An Alzheimer’s scholar on the paradox of declining dementia rates
Although billions of dollars have been poured into potential pharmaceutical cures for dementia, particularly Alzheimer’s…
Opinion: The AMA needs to declare a national mental health emergency
As the pandemic continues to disrupt life across the U.S., a staggering number of Americans…
The stages of pandemic emotion: from horror to hope to rage — and now, an anxious optimism
The first days of summer this year saw Americans jubilant, as Covid-19 cases plummeted across…
STAT+: AstraZeneca to pay $560,000 to settle claims of discriminating against women sales reps
Following a federal investigation, AstraZeneca (AZN) has agreed to pay $560,000 to hundreds of sales…
A nonprofit app marketplace & tales from a tele-ICU
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: STAT+ Conversation: Making health care accountable
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: Francis Collins to step down as NIH director; Research confirms decline in Pfizer vaccine protection against ‘breakthrough’ infection
Good morning, everyone, and how are you today? Gray skies are hovering over the Pharmalot…
STAT+: Carbon Health pushes further into home care with remote monitoring purchase
On a buying streak, hybrid care company Carbon Health on Tuesday purchased Alertive Healthcare, a…
STAT+: Vedanta touts positive new data for its C. diff microbiome therapeutic — but is it too late?
Vedanta Biosciences is touting positive new Phase 2 results for a microbe-based treatment for C….
Opinion: Why U.S. pandemic management has failed: lack of attention to America’s epidemic engines
Few U.S. journalists, politicians, or public health officials expressed any extraordinary concern when reports of…
Opinion: A likely new treatment for Covid-19 was made possible by government-funded innovation
Last week, Merck and Ridgeback Biotherapeutics announced Phase 3 results of molnupiravir, an oral antiviral…
‘Information alone is not enough’: New Jackson Heart Study leader commits to putting research into action
There’s a reason why the nation’s largest and longest-running study of cardiovascular disease in African…
STAT+: First they targeted generic drugs. Now a group of hospitals wants to build a better digital health marketplace
It’s one of the biggest market failures in modern medicine. The lack of a widely…
At a rural ICU, Covid-19’s summer surge put telehealth to the test
On the surface, there’s little about Whitfield Regional Hospital that would make it a safety…
NIH Director Francis Collins to step down
WASHINGTON — Francis Collins, the pioneering genetics researcher and longtime director of the National Institutes…
STAT+: The Merck Covid-19 pill may be a game changer, but questions are already being raised about cost
Behind the unvarnished enthusiasm over an experimental Covid-19 pill, questions are emerging about the cost…
In research first, jolts from a customized brain implant provided immediate relief to a severely depressed patient, scientists say
When Sarah, 36 years old and severely depressed, sat down in a lab with a…
What we know — and don’t know — about Merck’s new Covid-19 pill
The announcement that a pill from Merck and partner Ridgeback Biotherapeutics kept Covid patients out…
STAT+: Pharmalittle: J&J to seek emergency use of Covid-19 vaccine booster; Pfizer loses legal battle over Medicare co-pay programs
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
.jpg)
Two scientists win Nobel Prize in medicine for how we sense temperature and touch
Two California-based scientists have won the 2021 Nobel Prize in medicine or physiology on Monday…
Opinion: FDA’s naming rule for biosimilars has undermined Congress and health care
I recently tried to order white blood cell growth factor (pegfilgrastim) biosimilar for one of…
STAT+: The health tech tracker for the fourth quarter: the decisive industry events to watch
Winter may be coming (again), but the digital health sector remains red-hot. Fueled by fresh…
STAT+: The biotech scorecard for the fourth quarter: 19 stock-moving events to watch
The year is almost over! Here is STAT’s biotech scorecard, our regular ledger of stock-moving…
Opinion: On a day to celebrate the Nobel in medicine, a stain still mars the institute that awards it
As the Nobel Assembly at Sweden’s Karolinska Institute announces the winners of the 2021 Nobel…
STAT+: Inside the downfall of longevity crusader Aubrey de Grey — and the cult of personality that concealed a pattern of harassment
“You’ve been a bad boy,” Moses Znaimer, the bespectacled media mogul often referred to as…
STAT+: Pfizer loses a lawsuit alleging the U.S. illegally limits use of patient copay assistance programs
In a setback to the pharmaceutical industry, a federal judge ruled that programs Pfizer (PFE)…